Professor of Medicine at Harvard Medical School and Senior Investigator in the Section on Genetics and Epidemiology at Joslin Diabetes Center in Boston, MA. To facilitate translational research on ...

An expert task force on Thursday released a new and much-anticipated approach for diagnosing kidney function, saying there is no need for controversial algorithms that consider race in the assessment ...

Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can ...

FDA staffers recently flagged multiple concerns around Mallinckrodt’s terlipressin for a type of kidney failure, including whether meeting the surrogate endpoint in its phase 3 study actually ...

Heart failure patients treated with finerenone (Kerendia; Bayer AG) are more likely to have an early decline in kidney function than those treated with placebo, but the decline should not be construed ...